Cyclosporin A

Agent Name
Cyclosporin A
CAS Number
59865-13-3
Formula
C62-H111-N11-O12
Major Category
Biological Agents
Cyclosporin A formula graphical representation
Synonyms
(R-(R*,R*-(E)))-Cyclic(L-alanyl-D-alanyl-N-methyl-L-leucyl-N-methyl-L-leucyl-N-methyl-L-valyl-3-hydroxy-N,4-dimethyl-L-2-amino-6-octenoyl-L-alpha-aminobutyryl-N-methylglycyl-N-methyl-L-leucyl-L-valyl-N-methyl-L-leucyl); Antibiotic S 7481F1; Ciclosporin; Ciclosporina [INN-Spanish]; Ciclosporine [INN-French]; Ciclosporine [INN]; Ciclosporinum [INN-Latin]; Cipol N; Consupren; Cyclo(((E)-(2S,3R,4R)-3-hydroxy-4-methyl-2-(methylamino)-6-octenoyl)-L-2-aminobutyryl-N-methylglycyl-N-methyl-L-leucyl-L-valyl-N-methyl-L-leucyl-L-alanyl-D-alanyl-N-methyl-L-leucyl-N-methyl-L-leucyl-N-methyl-L-valyl); Cyclo(L-alanyl-D-alanyl-N-methyl-L-leucyl-N-methyl-L-leucyl-N-methyl-L-valyl-((3R,4R,6E)-6,7-didehydro-3-hydroxy-N,4-dimethyl-L-2-aminooctanoyl-L-2-aminobutanoyl-N-methylglycyl-N-methyl-L-leucyl-L-valyl-N-methylleucyl); Cyclosporin; Cyclosporine; Cyclosporine A; DRG-0275; Gengraf; Neoplanta; Neoral; OL 27-400; Ramihyphin A; Restasis; S 7481F1; S-Neoral; Sandimmun; Sandimmun Neoral; Sandimmune; Sang 35; Sangcya; [ChemIDplus]
Category
Mycotoxins
Description
White solid; [Merck Index] White powder; [MSDSonline]
Sources/Uses
Produced by Tolypocladium inflatum and other fungi imperfecti; An immunosuppressant; Veterinary applications include control of immune-mediated dermatological diseases; [Merck Index] Used in organ transplantation; [HSDB] Used as an immunosuppressive drug since the 1980s; [IARC]
Comments
A nephrotoxin and hepatotoxin; [CAMEO] Directly toxic to the kidney; [Olson, p. 41] Causes chronic tubulointerstitial nephritis; [Ford, p. 194] In studies of rats, can cause male sterility and fetotoxicity at high doses; Enhances the development of lymphomas in animals and humans; [IARC] When used as a drug, nephrotoxicity occurs in all patients and is the limiting factor in its use. Nephrotoxicity is associated with trough plasma levels >250 ng/mL and hepatotoxicity with trough levels >1000 ng/mL; [HSDB]
Biomedical References

Adverse Effects

Hepatotoxin
Hepatoxic (a) from occupational exposure (secondary effect) or (b) in animal studies or in humans after ingestion
Nephrotoxin
Yes
IARC Carcinogen
Established
NTP Carcinogen
Human carcinogen

Diseases, Processes, and Activities Linked to This Agent

Other Information
No other related information on this agent was found.